|1.||Burkart, Martin: 1 article (11/2011)|
|2.||Zimmermann, Andrea: 1 article (11/2011)|
|3.||Eggeling, Thomas: 1 article (11/2011)|
|4.||Regitz-Zagrosek, Vera: 1 article (11/2011)|
|5.||Zahler, Stefan: 1 article (08/2010)|
|6.||Totzke, Frank: 1 article (08/2010)|
|7.||Koch, Egon: 1 article (08/2010)|
|8.||Fürst, Robert: 1 article (08/2010)|
|9.||Vollmar, Angelika M: 1 article (08/2010)|
|10.||Zirrgiebel, Ute: 1 article (08/2010)|
11/15/2011 - "The efficacy of quantified Crataegus extract in chronic heart failure (CHF) has been assessed in numerous clinical studies. "
11/15/2011 - "Baseline severity but not gender modulates quantified Crataegus extract effects in early heart failure--a pooled analysis of clinical trials."
05/01/1999 - "Crataegus extract is used in cardiology for the treatment of mild to moderate heart failure (NYHA II) in Germany. "
11/01/1996 - "Crataegus extract is used in cardiology for the treatment of moderate heart failure (NYHA II). "
07/01/2001 - "The data show that Crataegus extract WS 1442 is clinically effective in patients with congestive heart failure corresponding to NYHA class II."
|2.||Heart Diseases (Heart Disease)
09/01/1993 - "Crataegus extract (0.01 or 0.05%) was applied to the heart from 5 min before ischemia through the first 10 min after reperfusion. "
09/01/1993 - "The effect of the water-soluble fraction of Crataegus (Crataegus extract) on the cardiac mechanical and metabolic function was studied in the isolated, perfused working rat heart during ischemia and reperfusion. "
09/01/1993 - "In the heart treated with the high concentration of Crataegus extract, the reperfusion-induced recovery of the energy metabolism was accelerated, and the level of lactate during ischemia was lower than that in the control heart, although the myocardial levels of free fatty acids during ischemia and reperfusion were not greatly affected. "
|2.||Platelet-Derived Growth Factor beta Receptor (Receptor, Platelet Derived Growth Factor beta)
|4.||Nonesterified Fatty Acids (NEFA)